Ligelizumab
From Infogalactic: the planetary knowledge core
| Monoclonal antibody | |
|---|---|
| Type | Whole antibody |
| Source | Humanized |
| Target | IGHE |
| Identifiers | |
| CAS Number | 1322627-61-1 |
| ATC code | none |
Ligelizumab (INN) is a humanized monoclonal antibody that binds to IGHE. It acts as an immunomodulator.[1]
Adverse drug effects
Lua error in package.lua at line 80: module 'strict' not found.
References
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
<templatestyles src="Asbox/styles.css"></templatestyles>
 |
This monoclonal antibody-related article is a stub. You can help Wikipedia by expanding it. |
Categories:
- Drugs that are a monoclonal antibody
- Articles without EBI source
- Chemicals that do not have a ChemSpider ID assigned
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs not assigned an ATC code
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- Articles using small message boxes
- Monoclonal antibodies
- Monoclonal antibody stubs
